Loxo Oncology, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Loxo Oncology, Inc.
CIK #0001581720
EDGAR Form CIK 2011 - 2023
10-K [0001581720]
10-Q [0001581720]
3 [0001581720]
4 [0001581720]
8-K [0001581720]
D [0001581720]
SC 13D [0001581720]
SC 13G [0001581720]
Form 13D/13G Filer Form 13D/13G Subject Filed
Lilly Eli & Co Loxo Oncology Inc [2019-01-15]
Price T Rowe Associates Inc /MD/ Loxo Oncology Inc [2018-02-14]
Sands Capital Management LLC Loxo Oncology Inc [2018-02-14]
Vanguard Group Inc Loxo Oncology Inc [2018-02-09]
BlackRock Inc Loxo Oncology Inc [2018-02-01]
Wellington Management Group LLP Loxo Oncology Inc [2017-02-09]
BlackRock Inc Loxo Oncology Inc [2017-01-30]
Access Industries Management LLC Loxo Oncology Inc [2017-01-18]
Adage Capital Partners GP LLC Loxo Oncology Inc [2017-01-06]
Victory Capital Management Inc Loxo Oncology Inc [2016-09-23]
View All
Form 3/4/5 Subject 2011 - 2023
Loxo Oncology, Inc.
Bilenker Joshua H.
Van Naarden Jacob
Nanda Nisha
Naider Avi Z.
Mayleben Timothy M
Kunkel Lori Anne
Harr Steve
Fuhrman Alan
Flaherty Keith T.
View All
Terms | Privacy | Guide
tony@aum13f.com